Cargando…

Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy

Immune checkpoint inhibitors (ICIs) significantly prolong survival in patients with metastatic melanoma but can lead to serious immune-related adverse events. In this report, we described a case of atypical neuropathy caused by nivolumab plus ipilimumab combination therapy before primary tumor resec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kambayashi, Yumi, Fujimura, Taku, Kuroda, Hiroshi, Otsuka, Atsushi, Irie, Hiroyuki, Aiba, Setsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250384/ https://www.ncbi.nlm.nih.gov/pubmed/32508619 http://dx.doi.org/10.1159/000506976

Ejemplares similares

Successful Treatment of Multiple Metastatic Melanoma with Nivolumab, Ipilimumab plus Denosumab Combined Therapy
por: Yoshida, Saaya, et al.
Publicado: (2019)

Sequential Therapy with Nivolumab Followed by Ipilimumab Induces Complete Response in Metastatic Melanoma of the Lung but with Severe Hepatotoxicities
por: Furudate, Sadanori, et al.
Publicado: (2016)

Successful Treatment of Nivolumab-Resistant Multiple In-Transit Melanomas with Ipilimumab and Topical Imiquimod
por: Fujimura, Taku, et al.
Publicado: (2018)

Successful Treatment of a Patient with anti-PD1 Antibody-Resistant Advanced Mucosal Melanoma with Nivolumab, Ipilimumab plus Denosumab Combination Therapy
por: Fujimura, Taku, et al.
Publicado: (2020)

Successful Treatment of Unresectable Advanced Melanoma by Administration of Nivolumab With Ipilimumab Before Primary Tumor Resection
por: Fujimura, Taku, et al.
Publicado: (2019)

Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab
por: Tanita, Kayo, et al.
Publicado: (2018)

Crosstalk between regulatory T cells (Tregs) and myeloid derived suppressor cells (MDSCs) during melanoma growth
por: Fujimura, Taku, et al.
Publicado: (2012)

Significance of BRAF Kinase Inhibitors for Melanoma Treatment: From Bench to Bedside
por: Fujimura, Taku, et al.
Publicado: (2019)

Treatment of Advanced Melanoma: Past, Present and Future
por: Fujimura, Taku, et al.
Publicado: (2020)

Serum Level of Soluble CD163 May Be a Predictive Marker of the Effectiveness of Nivolumab in Patients With Advanced Cutaneous Melanoma
por: Fujimura, Taku, et al.
Publicado: (2018)

Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma
por: Fujimura, Taku, et al.
Publicado: (2019)

Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma
por: Fujimura, Taku, et al.
Publicado: (2017)

Nivolumab plus ipilimumab in the treatment of advanced melanoma
por: Tsai, Katy K., et al.
Publicado: (2015)

First-in-human clinical study of novel technique to diagnose malignant melanoma via thermal conductivity measurements
por: Okabe, Takahiro, et al.
Publicado: (2019)

Pigmented Epithelioid Melanocytoma (Animal Types of Melanoma) on the Nose
por: Ohuchi, Kentaro, et al.
Publicado: (2018)

Metastatic PRAME-Expressing Juvenile Spitzoid Melanoma on the Buttock
por: Muto, Yusuke, et al.
Publicado: (2020)

Therapy-Resistant, Spontaneously Remitting Generalized Neutrophilic Eccrine Hidradenitis in a Healthy Patient Decreases the Expression of Dermcidin in Affected Eccrine Glands
por: Kambayashi, Yumi, et al.
Publicado: (2011)

Basal Cell Carcinoma with Spontaneous Regression: A Case Report and Immunohistochemical Study
por: Fujimura, Taku, et al.
Publicado: (2012)

Profiles of Cytotoxic T Lymphocytes in Cutaneous Lymphoid Hyperplasia of the Face
por: Furudate, Sadanori, et al.
Publicado: (2013)

Potential Use of Bisphosphonates in Invasive Extramammary Paget's Disease: An Immunohistochemical Investigation
por: Fujimura, Taku, et al.
Publicado: (2013)

Granulysin-Bearing Cells in the Skin Lesions of Acute Graft-versus-Host Disease: Possible Mechanisms for Hypohidrosis in Graft-versus-Host Disease
por: Furudate, Sadanori, et al.
Publicado: (2013)

Biomarkers for Predicting Efficacies of Anti-PD1 Antibodies
por: Kambayashi, Yumi, et al.
Publicado: (2019)

Topical and Systemic Formulation Options for Cutaneous T Cell Lymphomas
por: Fujimura, Taku, et al.
Publicado: (2021)

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma
por: Wolchok, Jedd D., et al.
Publicado: (2022)

Serum levels of soluble CD163 and CXCL5 may be predictive markers for immune-related adverse events in patients with advanced melanoma treated with nivolumab: a pilot study
por: Fujimura, Taku, et al.
Publicado: (2018)

Immunomodulatory effect of peritumorally administered interferon-beta on melanoma through tumor-associated macrophages
por: Kakizaki, Aya, et al.
Publicado: (2015)

Systemic Lupus Erythematosus Accompanied by Psoriasis Induces IL-27-Producing Cells in Both Affected Areas of the Skin
por: Tojo, Gen-ichi, et al.
Publicado: (2012)

Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers
por: Fujimura, Taku, et al.
Publicado: (2020)

Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
por: Chapman, Paul B, et al.
Publicado: (2021)

Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163(+) Arginase 1(+) M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
por: Fujimura, Taku, et al.
Publicado: (2013)

Successful Treatment of Adult-Onset Erythromelalgia with Steroid Pulse and Pregabalin
por: Kakizaki, Aya, et al.
Publicado: (2012)

Bullous Pemphigoid Accompanied by Aplastic Anemia: The Induction of IL-17-Producing Cells in the Affected Areas of the Skin
por: Fujimura, Taku, et al.
Publicado: (2012)

Immunohistochemical Similarities between Lichen Sclerosus et Atrophicus and Morphea: A Case Study
por: Kakizaki, Aya, et al.
Publicado: (2015)

Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer
por: Fujimura, Taku, et al.
Publicado: (2018)

Successful Treatment of Advanced Primary Cutaneous Peripheral T-Cell Lymphoma with Oral Bexarotene Monotherapy
por: Sato, Yota, et al.
Publicado: (2018)

Successful Treatment of Granuloma Faciale with Topical Tacrolimus: A Case Report and Immunohistochemical Study
por: Tojo, Gen-ichi, et al.
Publicado: (2012)

The best dosage of nivolumab plus ipilimumab combination for melanoma brain metastases
por: Fukumoto, Takeshi, et al.
Publicado: (2022)

Basosquamous Cell Carcinoma Developing from a Renal Transplantation Recipient
por: Tsukada, Akira, et al.
Publicado: (2012)

Successful Treatment of Eccrine Porocarcinoma Metastasized to a Cervical Lymph Node with CyberKnife Radiosurgery
por: Fujimura, Taku, et al.
Publicado: (2014)

Keratoacanthoma Accompanied by Multiple Lung Squamous Cell Carcinomas Developing in a Renal Transplant Recipient
por: Furudate, Sadanori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_17nupk97c1nn98uhi1tl8ohbf1